Lexeo Therapeutics, Inc. H-1B wage filings

New York, NY. Last filed in fiscal 2026. Figures cover every filing since fiscal 2020; none in the latest 12 months reach five.

Lexeo Therapeutics, Inc. filed 5 wage applications for H-1B and similar visas from fiscal 2021 to fiscal 2026. The median wage it offered was $195,000, 20.1% above the government's prevailing wage for the same jobs.

Filings since FY2021
5
Positions covered
5
Certified
100.0%
Job titles
4
Worksite cities
3
Last filed
FY2026

Offered wage since 2021

Lexeo Therapeutics, Inc. made 5 filings across 4 fiscal years since 2021, too few in most years to track the wage year by year. Its busiest full year was fiscal 2022, with 2 filings.

Fiscal years run October to September. Fiscal 2026 is still running: these figures cover October 2025 to June 2026.

Lexeo Therapeutics, Inc. by fiscal year

Fiscal yearFilingsMedian offeredvs year beforeMedian prevailingvs prevailing
2026 (Oct to Jun)1n/an/an/an/a
20250n/an/an/an/a
20241n/an/an/an/a
20230n/an/an/an/a
20222n/an/an/an/a
20211n/an/an/an/a

Offered wage by job title

Middle half of offered wagesMedian offered wageMedian prevailing wage

Job titleFilingsMedian offeredOffered range and prevailing wagevs prevailing
Director, Research2$204,000+2.4%
Associate Director - Research1$195,000+36.1%
Lab Operations Research Scientist1$140,000+20.1%
Senior Clinical Trial Manager1$180,000+20.6%

Where the jobs are

WorksiteFilingsMedian offered
New York, NY3$195,000
Durham, NC1$180,000
La Jolla, CA1$208,000

By visa type: 5 H-1B. By outcome: 5 certified.

Seniority of the jobs filed

Level I, entry0%
Level II, qualified20%
Level III, experienced60%
Level IV, fully competent20%

The government assigns each job one of four wage levels. A higher level means a higher legal minimum.

What these numbers are

Source: U.S. Department of Labor, OFLC disclosure data. How we clean and count it.

Other employers based in New York, NY